參考資料:
Tian L, Cao J, Zhao T, Liu Y, Khan A, Cheng G. The Bioavailability, Extraction, Biosynthesis and Distribution of Natural Dihydrochalcone: Phloridzin. Int J Mol Sci. 2021 Jan 19;22(2):962.
Allegra G, Niutta R, Pastore G. Biohistochemical studies on renal phosphatases in dogs with phlorhizin diabetes after vitamin and hormone administration. Arch De Vecchi Anat Patol. 1954 Jun;22(1):281-95.
Wright EM. SGLT2 Inhibitors: Physiology and Pharmacology. Kidney360. 2021 Sep 17;2(12):2027-2037.
Anderson SL, Marrs JC. Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother. 2012 Apr;46(4):590-8.
Green JB, McCullough PA. Roles for SGLT2 Inhibitors in Cardiorenal Disease. Cardiorenal Med. 2022 Jul 14.